Author

V. Rouilly

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Llibre· 2 shared B. Charbit· 2 shared D. Duffy· 2 shared E. Filander· 2 shared E. Nemes· 2 shared H. Africa· 2 shared H. Mulenga· 2 shared M. L. Albert· 2 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Llibre

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

A. Llibre, N. Smith, V. Rouilly, M. Musvosvi, E. Nemes, C. Posseme, S. Mabwe, B. Charbit, S. Kimbung Mbandi, E. Filander, H. Africa, V. Saint-Andre, V. Bondet, P. Bost, H. Mulenga, , D. Duffy

The paper examines how tuberculosis alters immune-metabolic pathways, leading to changes in IL-1 responses in TB patients compared to latent infection and post-treatment.

bioRxiv · Dec 17, 2020Immunology

Immune profiling in M. tuberculosis infection enables stratification of patients with active disease

D. Duffy, E. Nemes, A. Llibre, V. Rouilly, E. Filander, H. Africa, S. Mabwe, L. Jaxa, B. Charbit, M. Musvosvi, H. Mulenga, The Milieu Interieur Consortium, S. Thomas, M. Hatherill, N. Bilek, , M. L. Albert

This study compares TruCulture and QFT methods for detecting active TB, finding TruCulture better distinguishes active disease from latent infection using IFN-gamma and cytokine responses.

bioRxiv · Mar 18, 2019 · PreprintImmunology